Your Current Position: News and Trends
-
292020-04The NMPA issued a notice to solicit public opinion on six documents , including《Special Provisions on Registration Administration of Traditional Chinese Medicine (Draft for public review)》
-
262020-04The NMPA and National Health Commission of the PRC issued the announcement about the quality management standard for drug clinical trials (No. 57 of 2020)
-
072020-04The project Tofacitinib successfully had passed on-site inspection of CFDI
-
242020-012020-01-14 to17，The project Enalapril Maleate successfully had passed on-site inspection of CFDI.
-
172020-01The project Pitavastatin Calcium successfully had passed on-site inspection of CFDI
-
302019-112019-11-27 to 29，The project Valsartan and Amlodipine Tablets(I) successfully had passed on-site inspection of CFDI
-
302019-11The project Levamlodipine Besylate Tablet successfully had passed on-site inspection of CFDI
-
302019-11The project Dantraline sodium successfully had passed on-site inspection of CFDI
-
302019-09The project Ticagrelor sodium successfully had passed on-site inspection of CFDI
-
302019-09The project Omeprazole sodium successfully had passed on-site inspection of CFDI
Beijing Scinovo Laboratories Ltd. Address: 3rd Floor, Building 2, Jinweikai Technology Park, No. 8,Haiying Road, Science City, Fengtai District, Beijing,China |
|
Copyright ? Beijing Scinovo Laboratories Ltd. All rights reserved Record number: Beijing ICP No. 17066146